COMPUTED TOMOGRAPHY OF RAMBOUILLET SHEEP AFFECTED WITH NEURONAL CEROID LIPOFUSCINOSIS

Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses

INTRODUCTION

The neuronal ceroid lipofuscinoses (NCLs; Batten disease) are a group of fatal neurodegenerative lysosomal storage diseases of children caused by various mutations in a range of genes. Forms associated with mutations in two of these, CLN5 and CLN6, are being investigated in well-established sheep models. Brain atrophy leading to psychomotor degeneration is among the defining features, as is regional progressive ossification of the inner cranium. Ongoing viral-mediated gene therapy trials in these sheep are yielding encouraging results. In vivo assessment of brain atrophy is integral to the longitudinal monitoring of individual animals and provides robust data for translation to treatments for humans.

METHODS

Computed tomography (CT)-based three-dimensional reconstruction of the intracranial volume (ICV) over time reflects the progression of cortical brain atrophy, verifying the use of ICV measurements as a surrogate measure for brain size in ovine NCL.

RESULTS

ICVs of NCL-affected sheep increase for the first few months, but then decline progressively between 5 and 13 months in CLN5^-/- sheep and 11-15 months in CLN6^-/- sheep. Cerebral ventricular volumes are also increased in affected animals. To facilitate ICV measures, the radiodensities of ovine brain tissue and cerebrospinal fluid were identified. Ovine brain tissue exhibited a Hounsfield unit (HU) range of (24; 56) and cerebrospinal fluid a HU range of (-12; 23).

CONCLUSIONS

Computed tomography scanning and reconstruction verify that brain atrophy ovine CLN5 NCL originates in the occipital lobes with subsequent propagation throughout the whole cortex and these regional differences are reflected in the ICV loss.

Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions

The neuronal ceroid lipofuscinoses (NCLs) are devastating inherited progressive neurodegenerative diseases, with most forms having a childhood onset of clinical signs. The NCLs are characterized by progressive cognitive and motor decline, vision loss, seizures, respiratory and swallowing impairment, and ultimately premature death. Different forms of NCL result from mutations in at least 13 genes. The clinical signs of some forms overlap significantly, so genetic testing is the only way to definitively determine which form an individual patient suffers from. At present, an effective treatment is available for only one form of NCL. Evidence of NCL has been documented in over 20 canine breeds and in mixed-breed dogs. To date, 12 mutations in 8 different genes orthologous to the human NCL genes have been found to underlie NCL in a variety of dog breeds. A Dachshund model with a null mutation in one of these genes is being utilized to investigate potential therapeutic interventions, including enzyme replacement and gene therapies. Demonstration of the efficacy of enzyme replacement therapy in this model led to successful completion of human clinical trials of this treatment. Further research into the other canine NCLs, with in-depth characterization and understanding of the disease processes, will likely lead to the development of successful therapeutic interventions for additional forms of NCL, for both human patients and animals with these disorders.

Use of model organisms for the study of neuronal ceroid lipofuscinosis

Neuronal ceroid lipofuscinoses are a group of fatal progressive neurodegenerative diseases predominantly affecting children. Identification of mutations that cause neuronal ceroid lipofuscinosis, and subsequent functional and pathological studies of the affected genes, underpins efforts to investigate disease mechanisms and identify and test potential therapeutic strategies. These functional studies and pre-clinical trials necessitate the use of model organisms in addition to cell and tissue culture models as they enable the study of protein function within a complex organ such as the brain and the testing of therapies on a whole organism. To this end, a large number of disease models and genetic tools have been identified or created in a variety of model organisms. In this review, we will discuss the ethical issues associated with experiments using model organisms, the factors underlying the choice of model organism, the disease models and genetic tools available, and the contributions of those disease models and tools to neuronal ceroid lipofuscinosis research. This article is part of a Special Issue entitled: The Neuronal Ceroid Lipofuscinoses or Batten Disease.

Computed tomography and cross-sectional anatomy of the brain in clinically normal dogs

OBJECTIVE

To provide a detailed anatomic description of brain structures in clinically normal dogs by means of computed tomography (CT).

ANIMALS

4 clinically normal adult German Shepherd Dogs weighing 30 to 35 kg.

PROCEDURE

Each dog was anesthetized and positioned in ventral recumbency for CT examination of the brain; transverse scans were completed at 2-mm intervals from the cribriform plate of the ethmoid bone to the cranial part of the atlas by use of a third-generation CT scanner. Contrast material was injected IV, and a second series of scans was completed. Images (with or without contrast) from all dogs were reviewed by use of a soft tissue setting (window width, 150 Hounsfield units; window level, 50 Hounsfield units). One of the dogs was euthanatized, and a 3.5% formaldehyde solution was perfused via the common carotid arteries. After fixation, the brain was embedded in gelatin and sectioned into 5-mm-thick transverse sections by use of a stainless-steel knife. Anatomic sections were photographed and compared with the corresponding CT views.

RESULTS

Most features of the brain that were identified on anatomic sections could be identified on the corresponding CT scans despite the low contrast between structures, particularly if adjacent bony and soft tissue structures were used as landmarks. Additional anatomic structures surrounding the brain were also identifiable on the CT images.

CONCLUSIONS AND CLINICAL RELEVANCE

Images obtained in this study could be used as a guide for evaluation of CT images of the brain in dogs with brain diseases.

Neuronal ceroid lipofuscinosis in Rambouillet sheep: characterization of the clinical disease

A chronic progressive, neurodegenerative disease has been identified in 4 closely related flocks of purebred Rambouillet sheep. Blindness, circling, proprioceptive deficits, reduced cognition, and poor body condition are the main clinical signs. Prominent lesions include markedly decreased cerebral size and weight, enlarged cerebral ventricles, and intraneuronal accumulations of autofluorescent pigment. Affected sheep usually die between 1 and 2 years of age. The clinical signs and postmortem findings are consistent with neuronal ceroid-lipofuscinosis.